Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019163 (
hepatitis B
)
38,309
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Systemic vasculitis, which had been a consistently fatal disorder, became curable, with a sometimes chronic progression, when treatment with corticosteroids in association with immunosuppressive drugs was introduced. Treatment must be adapted according to causative factors, confirmed prognostic indicators, risk of recurrence and the need to reduce to a minimum iatrogenic side effects. Treatment of periarteritis nodosa, not linked to
hepatitis B
virus or to the Churg and Strauss syndrome, is based on high-dose corticosteroid treatment, associated with cyclophosphamide in intravenous bolus in severe forms.
Microscopic polyangiitis
and Wegener's granulomatosis usually require treatment with immunosuppressive drugs. These vasculitides have a high rate of recurrence and are responsible for high morbidity. Vasculitides associated to viral infections should receive specific treatment: plasma exchange and antiviral treatment (interferon, lamivudin) for periartiritis nodosa with
hepatitis B
, and interferon and ribavirin for cryoglobulinaemia associated with hepatitis C virus.
...
PMID:[Treatment of systemic vasculitides]. 1192 54